About: Serologic responses of 42 MERS-coronavirus-infected patients according to the disease severity

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Serologic responses of 42 MERS-coronavirus-infected patients according to the disease severity Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Serologic responses of 42 MERS-coronavirus-infected patients according to the disease severity
Creator	Kim, Yae-Jean Drosten, Christian Kang, Cheol-In Ko, Jae-Hoon Kang, Eun-Suk Kang, Ji-Man Song, Jae-Hoon Hahn, Myong-Joon Seok, Hyeri Müller, Marcel Cho, Sun Chung, Ryeon Ha, Young Kim, So Lee, Ji Peck, Kyong Chung, Chi Park, Eun Joon, Ik Yang Baek, Jin
topic	covid:bcc9e9497e21c2025ff768a86dc9c44fd53fd7e0#this
Source	Elsevier; Medline; PMC
abstract	Abstract We evaluated serologic response of 42 Middle East respiratory syndrome coronavirus (MERS-CoV)-infected patients according to 4 severity groups: asymptomatic infection (Group 0), symptomatic infection without pneumonia (Group 1), pneumonia without respiratory failure (Group 2), and pneumonia progressing to respiratory failure (Group 3). None of the Group 0 patients showed seroconversion, while the seroconversion rate gradually increased with increasing disease severity (0.0%, 60.0%, 93.8%, and 100% in Group 0, 1, 2, 3, respectively; P = 0.001). Group 3 patients showed delayed increment of antibody titers during the fourth week, while Group 2 patients showed robust increment of antibody titer during the third week. Among patients having pneumonia, 75% of deceased patients did not show seroconversion by the third week, while 100% of the survived patients were seroconverted (P = 0.003).
has issue date	2017-10-31(xsd:dateTime)
bibo:doi	10.1016/j.diagmicrobio.2017.07.006
bibo:pmid	28821364
has license	els-covid
sha1sum (hex)	bcc9e9497e21c2025ff768a86dc9c44fd53fd7e0
schema:url	https://doi.org/10.1016/j.diagmicrobio.2017.07.006
resource representing a document's title	Serologic responses of 42 MERS-coronavirus-infected patients according to the disease severity
has PubMed Central identifier	PMC7127792
has PubMed identifier	28821364
schema:publication	Diagnostic Microbiology and Infectious Disease
resource representing a document's body	covid:bcc9e9497e21c2025ff768a86dc9c44fd53fd7e0#body_text
is http://vocab.deri.ie/void#inDataset of	https://covidontheweb.inria.fr:4443/about/id/http/ns.inria.fr/covid19/bcc9e9497e21c2025ff768a86dc9c44fd53fd7e0
is schema:about of	named entity 'ACCORDING' named entity 'Group 0' named entity 'coronavirus' named entity 'robust' named entity 'patients' named entity 'Group 0' named entity 'PATIENTS' named entity 'SEROLOGIC' named entity 'RESPIRATORY FAILURE' named entity 'SYMPTOMATIC' named entity 'FOURTH' named entity 'GROUP 2' named entity 'DECEASED' named entity '0.001' named entity 'INCREASED' named entity 'ACCORDING' named entity 'INCREMENT' named entity '28P' named entity 'WEEK' named entity 'PNEUMONIA' named entity 'INFECTED' named entity 'DISEASE SEVERITY' named entity 'SEROCONVERSION' named entity 'ASYMPTOMATIC INFECTION' named entity 'GROUPS' named entity 'MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS' named entity 'GROUP' named entity 'ANTIBODY TITER' named entity 'MERS' named entity 'DISEASE SEVERITY' named entity '0.003' named entity 'PATIENTS' named entity 'DELAYED' named entity 'RATE' named entity 'DID' named entity 'INFECTED' named entity 'INCREASING' named entity 'ROBUST' named entity 'PROGRESSING TO' named entity 'SEVERITY' named entity 'INFECTION' named entity 'RESPONSE' named entity '100%' named entity 'EVALUATED' named entity 'ANTIBODY TITERS' named entity 'GROUP 3' named entity 'RESPONSES' named entity 'CORONAVIRUS' named entity 'SEROLOGIC' covid:arg/bcc9e9497e21c2025ff768a86dc9c44fd53fd7e0 named entity 'patients' named entity 'groups' named entity 'seroconversion' named entity 'asymptomatic infection' named entity 'Group 3' named entity 'serologic' named entity 'Middle East respiratory syndrome coronavirus' named entity 'Group 0' named entity 'pneumonia' named entity 'symptomatic infection'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software